|
VPS35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.979900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.602100E-02 |
| Normal-vs-Stage2 |
5.565800E-02 |
| Normal-vs-Stage3 |
1.62712999999259E-05 |
| Normal-vs-Stage4 |
2.195300E-04 |
| Stage1-vs-Stage2 |
3.544400E-01 |
| Stage1-vs-Stage3 |
8.801600E-04 |
| Stage1-vs-Stage4 |
3.476000E-03 |
| Stage2-vs-Stage3 |
1.675030E-01 |
| Stage2-vs-Stage4 |
2.057400E-01 |
| Stage3-vs-Stage4 |
9.158200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.556970E-03 |
| Normal-vs-AfricanAmerican |
6.30819999999366E-05 |
| Normal-vs-Asian |
1.500640E-01 |
| Caucasian-vs-AfricanAmerican |
2.914100E-02 |
| Caucasian-vs-Asian |
8.104800E-01 |
| AfricanAmerican-vs-Asian |
5.273800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78800999999229E-05 |
| Normal-vs-Female |
1.517800E-01 |
| Male-vs-Female |
3.261100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.582500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.966000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.70009999999455E-05 |
| Normal-vs-Age(81-100Yrs) |
8.024900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.951600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.562200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.060000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.052400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.099410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.298800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.520800E-01 |
| Normal-vs-Grade 2 |
1.567420E-01 |
| Normal-vs-Grade 3 |
6.33569999999306E-05 |
| Normal-vs-Grade 4 |
4.71769999954574E-07 |
| Grade 1-vs-Grade 2 |
1.632780E-01 |
| Grade 1-vs-Grade 3 |
1.086400E-02 |
| Grade 1-vs-Grade 4 |
1.119810E-03 |
| Grade 2-vs-Grade 3 |
3.742600E-03 |
| Grade 2-vs-Grade 4 |
3.51650000000037E-05 |
| Grade 3-vs-Grade 4 |
2.305800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.488000E-01 |
| Normal-vs-ccB subtype |
1.9450399999954E-05 |
| ccA subtype-vs-ccB subtype |
7.81769999957938E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.682100E-03 |
| Normal-vs-N1 |
1.205020E-01 |
| N0-vs-N1 |
4.713600E-01 |
|
|
